Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation.

Clin Sci (Lond) 2018 06 12;132(11):1155-1168. Epub 2018 Jun 12.

Department of Systems Medicine, University of "Tor Vergata", Rome, Italy

Metformin, a hypoglycemic drug used for treatment of type 2 diabetes, regulates inflammatory pathways. By using several models of intestinal inflammation, we examined whether metformin exerts anti-inflammatory effects and investigated the basic mechanism by which metformin blocks pathologic signals. Colitic mice given metformin exhibited less colonic inflammation and increased expression of active AMP-activated protein kinase, a mediator of the metabolic effects of metformin, in both epithelial and lamina propria compartments. Pharmacological inhibition of AMP-activated protein kinase reduced but did not prevent metformin-induced therapeutic effect as well as treatment of colitic mice with a pharmacological activator of AMP-activated protein kinase attenuated but did not resolve colitis. These data suggest that the anti-inflammatory effect of metformin relies on the control of additional pathways other than AMP-activated protein kinase. Indeed, metformin down-regulated p38 MAP kinase activation in colitic mice through an AMP-activated protein kinase-independent mechanism. Expression of active form of AMP-activated protein kinase was reduced in inflammatory bowel disease patients and treatment of mucosal cells of such patients with metformin enhanced AMP-activated protein kinase activation and reduced p38 MAP kinase activation, thereby inhibiting interleukin-6 expression. Our findings indicate that metformin is a good candidate for inhibiting pathological inflammation in the gut.

Download full-text PDF

Source
http://clinsci.org/lookup/doi/10.1042/CS20180167
Publisher Site
http://dx.doi.org/10.1042/CS20180167DOI Listing
June 2018
11 Reads
5.598 Impact Factor

Publication Analysis

Top Keywords

amp-activated protein
28
protein kinase
24
kinase activation
16
map kinase
12
p38 map
12
colitic mice
12
metformin
10
kinase
9
kinase reduced
8
expression active
8
amp-activated
7
protein
7
pharmacological activator
4
activator amp-activated
4
anti-inflammatory metformin
4
mice pharmacological
4
well treatment
4
treatment colitic
4
data anti-inflammatory
4
kinase attenuated
4

Similar Publications